Michael P. Dube
Chief Accounting Officer
Intellia Therapeutics, Inc. (NTLA)Equibles does not estimate personal net worth.
Get an email with a short summary when Intellia Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get NTLA alertsAbout Michael P. Dube
Michael P. Dube is recorded as Chief Accounting Officer at Intellia Therapeutics, Inc. (NTLA). Intellia Therapeutics, Inc. reported in an 8-K filed April 15, 2024 that Michael P. Dube was appointed principal accounting officer, effective April 10, 2024. The proxy statement of Intellia Therapeutics, Inc. reports total compensation of $1,342,904 for Michael P. Dube in fiscal 2024, including a base salary of $364,000. Intellia Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Intellia Therapeutics, Inc. includes Edward J. Dulac III (CFO), Andrew D. Schiermeier (COO), James Basta (General Counsel) and 7 others.
“On April 10, 2024, Intellia Therapeutics, Inc. (the "Company" or "Intellia") appointed Michael P. Dube, 46, as principal accounting officer of the Company.”
Affiliation history
-
Current
Company network
Leadership on record at Intellia Therapeutics, Inc.
- Edward J. Dulac III CFO
- Andrew D. Schiermeier COO
- James Basta General Counsel
- Bill Chase Board Member
- Brian Goff Board Member
- Georgia Keresty Board Member
- Georgia Keresty, Ph.D., M.P.H. Board Member
- John M. Leonard Board Member
- John M. Leonard, M.D. Board Member
- Muna Bhanji Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Intellia Therapeutics, Inc. (NTLA) | Vice President, Chief Accounting Officer, Former Interim Principal Financial Officer | $364,000 | $1,342,904 |